In bladder cancer, ALKBH5 specifically recognizes m6A sites, reduces the stability of CK2α mRNA, and then alters the level of CK2α, thereby affecting the glucose metabolic pathway 13, 39. The gene discussed is ALKBH5; the disease is urinary bladder carcinoma.